Pola Peresepan Obat Antihipertensi pada Pasien BPJS Kesehatan dibeberapa Apotek Daerah Bandung Periode November 2023

Dinda Juliana; Dika Pramita Destiani

doi:10.61132/obat.v2i5.612

Authors

Dinda Juliana Universitas Padjadjaran
Dika Pramita Destiani Universitas Padjadjaran

DOI:

https://doi.org/10.61132/obat.v2i5.612

Keywords:

Hypertension, Antihypertensive drugs, Prescription

Abstract

Hypertension is a non-communicable disease that always increases every year. Hypertension is known as a silent killer because patients who suffer from hypertension rarely feel the symptoms. Common symptoms of hypertension can be headaches in the back of the neck, blurred vision, and others. The blood pressure of hypertension sufferers is above 140/90 mmHg. This study aims to see the pattern of prescribing antihypertensive drugs in BPJS Kesehatan patients including gender, age, patient diagnosis, and combination of antihypertensive drug classes. The method used is descriptive observational research. This study was conducted using 195 prescriptions in the period November 2023. The results obtained were that hypertension sufferers were more dominated by women with a total of 131 sufferers with a percentage of 67% compared to men with a total of 64 sufferers with a percentage of 33%. The age most affected by hypertension is people aged 51 years - 75 years with a total of 143 people and a percentage of 73.33%. 92 of 195 (47.18%) patients did not have other diseases such as diabetes mellitus, hyperlipidemia, heart, GI, and asthma. Single therapy of antihypertensive drugs was most commonly prescribed by doctors with a total of 127 patients with a presentation of 65.13% compared to patients who used combination therapy of two or more antihypertensive drugs. Calcium antagonist or CCB drugs were most commonly used by BPJS patients at several pharmacies in the Bandung area used in the prescription analysis with a total of 107 patients with a percentage of 54.87%.

Downloads

Download data is not yet available.

References

Alkhusari, A., Anggita, K. D., & Satrio, A. (2023). Pengaruh pendidikan kesehatan dalam pelayanan home care terhadap perubahan perilaku gaya hidup penderita hipertensi. Jurnal ‘Aisyiyah Medika, 8(2), 42–51.

Ayu, D., Sinaga, A. F., Syahlan, N., Siregar, S. M., Sofi, S., Zega, R. S., Rusdi, A., Annisa, A., & Dila, T. A. (2022). Faktor-faktor yang menyebabkan hipertensi di Kelurahan Medan Tenggara. Martabe: Jurnal Pengabdian Kepada Masyarakat, 5(2), 649–664.

BPJS Kesehatan. (2014). Peraturan BPJS Kesehatan Nomor 1 Tahun 2014 tentang penyelenggaraan jaminan (pp. 1–48).

Bulsara, K. G., & Cassagnol, M. (2023). Amlodipin. Tersedia secara online di https://www.ncbi.nlm.nih.gov/books/NBK519508/. Diakses pada 28 Desember 2023.

Casey, A., & Benson, H. (2006). Menurunkan tekanan darah. Jakarta: Bhuana Ilmu Popular.

Elliott, W. J., & Ram, C. V. S. (2011). Calcium channel blockers. The Journal of Clinical Hypertension, 13(9), 687–689.

Ferrari, R., Pavasini, R., Camici, P. G., Crea, F., Danchin, N., Pinto, F., Manolis, A., Marzilli, M., Rosano, G. M. C., Lopez-Sendon, J., & Fox, K. (2019). Anti-anginal drugs-beliefs and evidence: Systematic review covering 50 years of medical treatment. European Heart Journal, 40(2), 190–194.

Gradman, A. H., Basile, J. N., Carter, B. L., & Bakris, G. L. (2011). Combination therapy in hypertension. The Journal of Clinical Hypertension, 13(3), 146–154.

Guerrero-García, C., & Rubio-Guerra, A. F. (2018). Combination therapy in the treatment of hypertension. Drugs Context, 6(7), 212531.

Hastuti, D. (2022). Profil peresepan obat antihipertensi pada pasien hipertensi di Apotek Afina. Majalah Farmaseutik, 18(3), 363–370.

Kandarini, Y. (2017). Tatalaksana farmakologi terapi hipertensi. Bali: RSUP Sanglah Denpasar.

Katanna, G., Agustina, W., & Afiif, A. (2022). Faktor-faktor yang mempengaruhi kejadian hipertensi pada masa menopause dengan menggunakan studi literatur. Professional Journal Health, 4(1), 103–113.

Katzung, B. G. (2001). Farmakologi dasar dan klinik. Jakarta: Salemba Medika.

Kemenkes RI. (2013). Laporan hasil riset kesehatan dasar (Riskesdas) Indonesia tahun 2013. Jakarta: Kemenkes RI.

Kemenkes RI. (2018). Laporan hasil riset kesehatan dasar (Riskesdas) Indonesia tahun 2018. Jakarta: Kemenkes RI.

Muhasi. (2016). JNC 8: Evidence-based guideline penanganan pasien hipertensi dewasa. Cdk, 43(1), 54–59.

Pudiastuti, R. D. (2013). Penyakit-penyakit mematikan. Yogyakarta: Nuha Medika.

Rahmadhani, M. (2021). Faktor-faktor yang mempengaruhi terjadinya hipertensi pada masyarakat di Kamping Bedagai Kota Pinang. Jurnal Kedokteran STM, 4(1), 52–62.

Rampengan, S. H. (2015). Resistant hypertension. Jurnal Kedokteran Yarsi, 23(2), 114–127.

Rustiani, E., Andrajati, R., & Arsyanti, L. (2018). Analisis penggunaan obat antihipertensi di poliklinik rawat jalan Rumah Sakit PMI Bogor: Perbandingan cost-effectiveness dan kualitas hidup pasien. Jurnal Ilmu Kefarmasian Indonesia, 12(2), 209–215.

Saraswati, S. (2009). Diet sehat untuk penyakit asam urat, diabetes, hipertensi, dan stroke. Yogyakarta: A Plus Book.

Solikin, & Muradi. (2020). Hubungan kadar kolesterol dengan derajat hipertensi pada pasien hipertensi di Puskesmas Sungai Jingah. Jurnal Keperawatan Suaka Insan, 5(1), 143–152.

Sumiati, L., Citraningtyas, G., & Yudistira, A. (2018). Analisis efektivitas biaya terapi antihipertensi pada pasien hipertensi rawat inap di RSU Pancaran Kasih GMIM Manado. Pharmacon, 7(1), 1–9.

Yunus, M., Aditya, I. W. C., & Eksa, D. R. (2021). Hubungan usia dan jenis kelamin dengan kejadian hipertensi di Puskesmas Haji Pemanggilan Kecamatan Anak Tuha Kab. Lampung Tengah. Jurnal Ilmu Kedokteran dan Kesehatan, 8(3), 229–239.

Zolotareva, O., Saik, O. V., Konigs, C., Bragina, E. Y., Goncharova, I. A., Freidin, M. B. M., Dosenko, V. E., Ivanisenko, V. A., & Hofestadt, R. (2019). Comorbidity of asthma and hypertension may be mediated by shared genetic dysregulation and drug side effects. Scientific Reports, 9, 19640. https://doi.org/10.1038/s41598-019-56094-5